Page last updated: 2024-09-02
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and carbidopa
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with carbidopa in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Gilgun-Sherki, Y; Mechoulam, R; Melamed, E; Offen, D | 1 |
Other Studies
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and carbidopa
Article | Year |
---|---|
The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Apomorphine; Cannabinoids; Carbidopa; Cell Line, Tumor; Dronabinol; Levodopa; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rotation; Substantia Nigra | 2003 |